EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Blood TRPC6 mRNA as a biomarker for Alzheimer's disease: a nationwide, multicenter study in China

Mei Pu, Yutong Wen, Yujing Chen, Jing Wang, Xiaoli Pan, Gang Wang, Xia Li, Guihong Wang, Chuantao Zuo, Jiong Shi, Liliang Zhu, Jie Wu und 12 weitere

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2026-10 · 18 (4)

DOI: 10.1002/dad2.70433 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, online erschienen am 05.11.2026. Verfasst von Mei Pu und 23 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Aging and Medicine, Huashan Hospital, State Key Laboratory of Medical Neurobiology Fudan University Shanghai Ch…. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Accessible blood‐based biomarkers remain needed for Alzheimer's disease (AD) screening and diagnosis. We investigated whether blood transient receptor potential canonical 6 (TRPC6) could serve as a potential biomarker for AD. METHODS We enrolled 1254 individuals, including 366 patients with AD, 735 cognitively unimpaired (CU) individuals, and 153 individuals with non‐AD neurological disorders. All patients with AD were confirmed to be amyloid beta positive (Aβ+) by Aβ positron emission tomography (PET). Blood TRPC6 messenger RNA (mRNA) levels were measured in all participants. In a subset, Aβ PET imaging and plasma biomarker assessments were performed. RESULTS Blood TRPC6 mRNA levels differed significantly among the CU, AD, and non‐AD groups, with the lowest levels observed in patients with AD. TRPC6 mRNA levels were associated with regional Aβ deposition and showed diagnostic performance comparable to several established plasma biomarkers, although slightly inferior to phosphorylated tau 217. DISCUSSION Blood TRPC6 mRNA is markedly reduced in AD and may represent an accessible and clinically relevant blood biomarker for AD.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid beta positron emission tomographyblood biomarkercognitive impairmenttransient receptor potential canonical 6

Autor:innen und Institutionen

  • National Clinical Research Center for Aging and Medicine, Huashan Hospital, State Key Laboratory of Medical Neurobiology Fudan University Shanghai China.
  • Institute for Translational Brain Research, State Key Laboratory of Brain Function and Disorders, MOE Frontiers Center for Brain Science Fudan University Shanghai China.
  • Institute of Neurology Huashan Hospital Fudan University Shanghai China.
  • Department of Nuclear Medicine & PET Center Huashan Hospital, Fudan University Shanghai China.
  • Department of Neurology Zhongshan Hospital, Fudan University Shanghai China.
  • Department of Neurology and Institute of Neurology Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital Shanghai China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Pu, M., Wen, Y., Chen, Y., Wang, J., Pan, X., Wang, G., Li, X., Wang, G., Zuo, C., Shi, J., Zhu, L., Wu, J., Ren, R., Cheng, X., Zhang, S., Wang, J., Liu, S., Li, L., Huang, F., …, & Wang, Y. (2026). Blood TRPC6 mRNA as a biomarker for Alzheimer's disease: a nationwide, multicenter study in China. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 18(4). https://doi.org/10.1002/dad2.70433

Vancouver

Pu M, Wen Y, Chen Y, Wang J, Pan X, Wang G, et al. Blood TRPC6 mRNA as a biomarker for Alzheimer's disease: a nationwide, multicenter study in China. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2026;18(4). doi:10.1002/dad2.70433

BibTeX
@article{Pu2026,
  author = {Pu, Mei and Wen, Yutong and Chen, Yujing and Wang, Jing and Pan, Xiaoli and Wang, Gang and Li, Xia and Wang, Guihong and Zuo, Chuantao and Shi, Jiong and Zhu, Liliang and Wu, Jie and Ren, Rujing and Cheng, Xiaoqin and Zhang, Shaowei and Wang, Jintao and Liu, Shujing and Li, Ling and Huang, Fei and Ding, Ding and Guan, Yihui and Zhong, Chunjiu and Zhao, Qianhua and Wang, Yizheng},
  title = {Blood TRPC6 mRNA as a biomarker for Alzheimer's disease: a nationwide, multicenter study in China},
  journal = {Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring},
  year = {2026},
  volume = {18},
  number = {4},
  doi = {10.1002/dad2.70433}
}
Kostenlos starten →